Search research articles
Contact Us
Filters
Showing results (601-610 of 613) with videos related to
Page
of 62
Sort By:
EMBO Molecular Medicine
|
January 3, 2026
A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data
Yue Tong, Marianne Becker, Ulrike Schierloh, et al.
Movement Disorders Clinical Practice
|
January 10, 2026
Voice and Speech in Atypical Parkinsonian Disorders
Federico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
Cancer Treatment and Research Communications
|
September 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
Spencer G Van Decar, Elizabeth L Carpenter, Alexandra M Adams, et al.
Journal of Neurosurgery. Pediatrics
|
July 19, 2024
Indications for cerebral revascularization for moyamoya syndrome in pediatric sickle cell disease determined by Delphi methodology
Adam P Robert, Ricardo A Hanel, P David Adelson, et al.
Journal of Diabetes Science and Technology
|
May 30, 2025
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
Julia K Mader, Jenise C Wong, Guido Freckmann, et al.
Cancer Discovery
|
March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Akash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Cureus
|
February 2, 2026
Improving Braden Scale Risk Assessment Documentation: A Two-Cycle Clinical Audit at Al-Managil Teaching Hospital, Sudan
Hala Omer Mohammed Taha, Amani Abdallah Alhajj Abdallah, Salih Ahmed, et al.
Scientific Data
|
November 19, 2025
14,441 Genomics-Based Validated Automated Comprehensive Clinicopathologic Correlations for Myeloid Neoplasms
Ahmed Elsafty, Yomna Ahmed, Taher F Halawa, et al.
Lancet (London, England)
|
January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
The Journal of Clinical Investigation
|
November 9, 2020
YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress
Elisa De Franco, Maria Lytrivi, Hazem Ibrahim, et al.
Page
of 62
Search research articles
Search
Showing results (601-610 of 613) with videos related to
Sort By:
Page
of 62
EMBO Molecular Medicine
|
January 3, 2026
A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data
Yue Tong, Marianne Becker, Ulrike Schierloh, et al.
Movement Disorders Clinical Practice
|
January 10, 2026
Voice and Speech in Atypical Parkinsonian Disorders
Federico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
Cancer Treatment and Research Communications
|
September 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
Spencer G Van Decar, Elizabeth L Carpenter, Alexandra M Adams, et al.
Journal of Neurosurgery. Pediatrics
|
July 19, 2024
Indications for cerebral revascularization for moyamoya syndrome in pediatric sickle cell disease determined by Delphi methodology
Adam P Robert, Ricardo A Hanel, P David Adelson, et al.
Journal of Diabetes Science and Technology
|
May 30, 2025
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
Julia K Mader, Jenise C Wong, Guido Freckmann, et al.
Cancer Discovery
|
March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Akash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Cureus
|
February 2, 2026
Improving Braden Scale Risk Assessment Documentation: A Two-Cycle Clinical Audit at Al-Managil Teaching Hospital, Sudan
Hala Omer Mohammed Taha, Amani Abdallah Alhajj Abdallah, Salih Ahmed, et al.
Scientific Data
|
November 19, 2025
14,441 Genomics-Based Validated Automated Comprehensive Clinicopathologic Correlations for Myeloid Neoplasms
Ahmed Elsafty, Yomna Ahmed, Taher F Halawa, et al.
Lancet (London, England)
|
January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
The Journal of Clinical Investigation
|
November 9, 2020
YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress
Elisa De Franco, Maria Lytrivi, Hazem Ibrahim, et al.
Page
of 62